SCHEMBL10071245

SCHEMBL10071245

CCOC(=O)C1CC1(C)[N+](=O)[O-]

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.39
LMNA P02545 5/20 0.36
CACNA1F O60840 2/20 0.35
CACNA1D Q01668 2/20 0.35
CACNA1S Q13698 2/20 0.35
CACNA1C Q13936 2/20 0.35
ADORA3 P0DMS8 1/20 0.35
ALDH1A1 P00352 7/20 0.34
SMN1; SMN2 Q16637 3/20 0.34
KMT2A Q03164 2/20 0.34
GAA P10253 1/20 0.34
POLB P06746 1/20 0.34
PKM P14618 1/20 0.34
HTT P42858 1/20 0.34
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
PPM1B O75688 1/20 0.33
PTPN1 P18031 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10071244 0.80 MAPT (0.35) MAPTLMNAKMT2AGAACYP3A4
SCHEMBL545243 0.77 MAPT (0.35) MAPTLMNAALDH1A1SMN1; SMN2KMT2A
SCHEMBL10071263 0.77 MAPT (0.35) MAPTLMNACACNA1FCACNA1DCACNA1S
SCHEMBL294716 0.75 LMNA (0.43) MAPTLMNAALDH1A1KMT2AGAA
SCHEMBL10071246 0.74 NLRP3 (0.32) KMT2AHTT
SCHEMBL16409442 0.72 LMNA (0.41) MAPTLMNAALDH1A1KMT2AGAA
SCHEMBL11042018 0.72 CYP1A2 (0.41) MAPTLMNAALDH1A1GAACYP3A4
SCHEMBL544747 0.71 KDM4E (0.32) MAPT
SCHEMBL17536921 0.71 MAPT (0.38) MAPTLMNAALDH1A1KMT2AGAA
SCHEMBL13730327 0.71 PPM1B (0.40) MAPTLMNAALDH1A1KMT2APKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8110699-B2 Cobalt-catalyzed asymmetric cyclopropanation of alkenes with α-nitrodiazoacetates UNIVERSITY OF SOUTH FLORIDA (US) 2012-02-07 US disclosed
US-20100081838-A1 Cobalt-Catalyzed Asymmetric Cyclopropanation of Alkenes with alpha-Nitrodiazoacetates UNIVERSITY OF SOUTH FLORIDA (US) 2010-04-01 US disclosed
US-20100076239-A1 ASYMMETRIC CYCLOPROPANATION OF ELECTRON-DEFICIENT OLEFINS WITH DIAZO REAGENTS UNIVERSITY OF SOUTH FLORIDA (US) 2010-03-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100076239-A1 ASYMMETRIC CYCLOPROPANATION OF ELECTRON-DEFICIENT OLEFINS WITH DIAZO REAGENTS DUOX2, DUOX1, PPOX MAPT 3165/4885LMNA 4809/4885CACNA1F 2202/4885
US-20100081838-A1 Cobalt-Catalyzed Asymmetric Cyclopropanation of Alkenes with alpha-Nitrodiazoacetates PPOX, IDH3A, HMOX2 MAPT 3287/4885LMNA 3375/4885CACNA1F 1437/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.